The indictment focuses on the marketing of Servier's diabetes drug Mediator, which was often prescribed off-label as a weight-loss drug but was tied to heart valve issues. The new charges are against 14 individuals as well as 11 institutions, including ...
Datum: 06-09-2017 18:31 | Bron: FiercePharma
Keer terug naar het nieuwsoverzicht: Mediator nieuws
